EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epiberberine suppresses the metastasis of head and neck squamous cell carcinoma cells by regulating the MMP ‐13 and JNK pathway

Hsin-Yu Ho, Mu-Kuan Chen, Chia-Chieh Lin iD, Yu-Sheng Lo, Yi-Ching Chuang, Ming-Ju Hsieh iD

Journal of Cellular and Molecular Medicine · 2023

DOI: 10.1111/jcmm.17954 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von Hsin-Yu Ho und 5 weiteren Autor:innen. Beteiligte Einrichtung: Oral Cancer Research Center, Changhua Christian Hospital, Changhua, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Head and Neck Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Council, Taiwan, Changhua Christian Hospital, National Science Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck squamous cell carcinoma (HNSCC) is one of the most common histological types of head and neck cancer. Epiberberine is a potent antitumour agent for several types of cancer. This study is aimed at investigating the regulatory and molecular mechanism of epiberberine on HNSSC cell metastasis. The results showed that epiberberine inhibited the motility of Ca9‐22 and FaDu cell lines at nontoxicity doses. Moreover, the epithelial‐mesenchymal transition (EMT)‐related proteins, vimentin, snail and slug, were found suppressing after epiberberine treatments. In addition, the JNK signalling cascade and the metalloproteinase 13 (MMP‐13) expression were also found downregulated by epiberberine. In conclusion, the present study demonstrates that epiberberine suppresses cell migration and invasion by regulating the JNK pathway and MMP‐13. These results suggest that epiberberine could be a potential antimetastatic agent in HNSCC cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellHead and Neck NeoplasmsAntineoplastic AgentsHumansSquamous Cell Carcinoma of Head and NeckMatrix Metalloproteinase 13MAP Kinase Signaling SystemCell Line, TumorEpithelial-Mesenchymal TransitionNeoplasm InvasivenessCell MovementGene Expression Regulation, NeoplasticBerberine

Stichwörter der Autor:innen

epiberberinehead and neck squamous cell carcinomamatrix metalloproteinase-13metastasis

Substanzen

Matrix Metalloproteinase 13Antineoplastic AgentsepiberberineBerberine

Autor:innen und Institutionen

  • Oral Cancer Research Center, Changhua Christian Hospital, Changhua, Taiwan.
  • Department of Otorhinolaryngology, Head and Neck Surgery, Changhua Christian Hospital, Changhua, Taiwan.
  • Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
  • Doctoral Program in Tissue Engineering and Regenerative Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
  • Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.

ORCID-Profile: Chia-Chieh Lin, Ming-Ju Hsieh

Förderung

  • National Science Council, Taiwan
  • Changhua Christian Hospital
  • National Science Council

Zitieren

APA

Ho, H. Y., Chen, M. K., Lin, C. C., Lo, Y. S., Chuang, Y. C., & Hsieh, M. J. (2023). Epiberberine suppresses the metastasis of head and neck squamous cell carcinoma cells by regulating the MMP ‐13 and JNK pathway. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.17954

Vancouver

Ho HY, Chen MK, Lin CC, Lo YS, Chuang YC, Hsieh MJ. Epiberberine suppresses the metastasis of head and neck squamous cell carcinoma cells by regulating the MMP ‐13 and JNK pathway. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.17954

BibTeX
@article{Ho2023,
  author = {Ho, Hsin-Yu and Chen, Mu-Kuan and Lin, Chia-Chieh and Lo, Yu-Sheng and Chuang, Yi-Ching and Hsieh, Ming-Ju},
  title = {Epiberberine suppresses the metastasis of head and neck squamous cell carcinoma cells by regulating the MMP ‐13 and JNK pathway},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2023},
  doi = {10.1111/jcmm.17954}
}
Kostenlos starten →